Microneedle Flu Vaccine Market Poised to Achieve Significant Growth in the Years to Come

1. Microneedle Flu Vaccine Market - Size, Share, Microneedle Flu Vaccine Market - Size, Share, Growth, Outlook, and Opportunity Analysis, Growth, Outlook, and Opportunity Analysis, 2018-2026 2018-2026 Vaccine is one of the most important biologic product used to prevent from infection of various diseases such as seasonal influenza, hepatitis, polio, diphtheria, Japanese encephalitis, measles, meningococcal disease, tetanus, haemophilus influenza type b, whooping cough among others. Vaccine consists of inactivated or killed form of microorganism or its protein. Vaccine generates anti- body response, which stimulates the immune system against specific diseases. Any future infections due to microorganism can be prevented by vaccinating the patients against that specific disease. Most of the vaccines are delivered through conventional needle and syringes, which has certain challenges such as needle phobia, discomfort in older and pediatric populations, requirement of special storage infrastructure, and need to visit the healthcare facility for its administration. Request Sample Copy of Research Report: https://www.coherentmarketinsights.com/insight/request-sample/2286 Microneedle flu vaccine resolves most of the challenges caused with conventional vaccines. It is of bandage-strip sized patch, which can be easily applied all over the skin. It consists of 100 solid water- soluble needles, which are capable to penetrate skin. Vaccine is encapsulated in the needles and is released as the needle tip dissolves within minutes, once the patch is applied over the skin surface. Skin produces local immune response against pathogens in the vaccine thereby, providing response similar to that of needle-based vaccine. The patch is peeled away and discarded like a used bandage strip. Microneedle Flu Vaccine Market - Market Dynamics Microneedle flu vaccine is still in nascent stage of development however, after its launch it would provide various advantages over conventional needle-based vaccines, which will drive growth of the market. Microneedle vaccine can be delivered easily at any location without special storage infrastructure, therefore it can be used even at distant location. This vaccine can be self- administered by anybody thereby, eliminating the need of clinic visit and assistance of physician.

2. This serves as an important advantage, especially in the emerging markets, where there is severe shortage of healthcare workers. According to World Health Organization, 2017 factsheet, Africa had an average of 1.30 health workers per 1000 population in 2015, which is way below the 4.5 per 1000 required for achievement of Sustainable Development Goals (SDGs). Globally, health workforce shortage is estimated to be 14.5 million, out of which Africa has the most severe health workforce (HWF) shortage, estimated to reach 6.1 million by 2030. Microneedle vaccine can address these issues if utilized on global scale. Moreover, it would avoid deaths caused from unavailability of vaccine by improving access to vaccination. For instance, according to United Nations Development Programme, measles vaccines have averted nearly 15.6 million deaths since 2000, globally. Report includes chapters which deeply display the following deliverable about industry : • Microneedle Flu Vaccine Market Research Objective and Assumption • Microneedle Flu Vaccine Market Purview - Report Description, Executive Summary, and Coherent Opportunity Map (COM) • Microneedle Flu Vaccine Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis • Global Microneedle Flu Vaccine Market, By Regions • Microneedle Flu Vaccine Market Competition by Manufacturers including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type. • Microneedle Flu Vaccine Market Manufacturers Profiles/Analysis including Company Basic Information, Manufacturing Base and Its Competitors. • Microneedle Flu Vaccine Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers of Raw Materials. • Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials Sourcing and Downstream Buyers • Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning and Distributors/Traders List. • Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer Preference Change and Economic/Political Environmental Change. • Microneedle Flu Vaccine Market Forecast including Production, Consumption, Import and Export Forecast by Type, Applications and Region. • Research Findings and Conclusion Key players in the global microneedle flu vaccine market are Micron Biomedical, Microdermics Inc., 3M Company, Inc., VaxInnate, and Vetter among others.

3. Inquire Here Before Purchase: https://www.coherentmarketinsights.com/insight/talk-to-analyst/2286 Microneedle Flu Vaccine Market Taxonomy On the basis of vaccine type, the global microneedle flu vaccine market is segmented into: Trivalent Flu Vaccine Quadrivalent Flu Vaccine • • On the basis of virus type, the global microneedle flu vaccine market is segmented into: Influenza Virus Type- A Influenza Virus Type- B • • On the basis of geography, the global microneedle flu vaccine market is segmented into: North America Latin America Europe Asia Pacific Middle East Africa • • • • • • About Coherent Market Insights Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702

4. Email: sales@coherentmarketinsights.com